This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Henan Zhiwei Biomedicine Co., Ltd., Henan Zhiwei Biomedicine Co., Ltd.. Active years: 2025-2026.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2025-2026
Title: Innovations of Chunhua Ma in Biotechnology
Introduction
Chunhua Ma is a notable inventor based in Xinxiang, China. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target Bruton's Tyrosine Kinase (BTK). His work has implications for the treatment of various diseases, including autoimmune disorders and cancer.
Latest Patents
Chunhua Ma holds 2 patents that focus on innovative compounds as BTK inhibitors. The first patent, titled "Substituted imidazolecarboxamide as Bruton's tyrosine kinase inhibitors," discloses a series of substituted imidazolecarboxamide compounds that are useful in treating autoimmune diseases, inflammatory diseases, cancer, and potentially allergies. The second patent, "Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhibitors," presents a compound or its pharmaceutically acceptable derivatives that serve similar therapeutic purposes.
Career Highlights
Chunhua Ma has worked with Henan Zhiwei Biomedicine Co., Ltd., where he has been involved in groundbreaking research and development. His expertise in the field has positioned him as a key player in the biotechnology sector.
Collaborations
Chunhua Ma has collaborated with notable colleagues, including Dandan Zhang and Shouning Yang. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Chunhua Ma's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments.